Sign Out
Salofalk 500mg tablets/suppositories/enemas are contraindicated in patients with: known hypersensitivity to salicylates or any of the excipients under Description; severe impairment of hepatic or renal function.
Suppository: Salofalk 500 mg suppositories must not be taken in: gastric and duodenal ulcers; haemorrhagic diathesis (predisposition to bleeding).
Salofalk 500 mg suppositories should not be used to treat infants and small children because of insufficient experience with this age group.
Use in pregnancy and lactation: In the first three months of pregnancy mesalazine should only be used if strictly indicated. Wherever possible, women wishing to have children should wait for a phase when as little as possible or no medication is required before beginning pregnancy. If the individual's condition allows, treatment should be interrupted in the last 2 - 4 weeks of pregnancy. As yet there is insufficient experience with the medicament during breast-feeding. If treatment becomes necessary during lactation, the child should be weaned.
